Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948697889> ?p ?o ?g. }
- W2948697889 endingPage "781" @default.
- W2948697889 startingPage "781" @default.
- W2948697889 abstract "Vancomycin-associated acute kidney injury (AKI) is a popular topic in the medical literature with few clear answers. While many studies evaluate the risk of AKI associated with vancomycin, few data are high quality and/or long in duration of follow-up. This review takes the clinician through an approach to evaluate a patient for risk of AKI. This evaluation should include patient assessment, antibiotic prescription, duration, and monitoring. Patient assessment involves evaluating severity of illness, baseline renal function, hypotension/vasopressor use, and concomitant nephrotoxins. Evaluation of antibiotic prescription includes evaluating the need for methicillin-resistant Staphylococcus aureus (MRSA) coverage and/or vancomycin use. Duration of therapy has been shown to increase the risk of AKI. Efforts to de-escalate vancomycin from the antimicrobial regimen, including MRSA nasal swabs and rapid diagnostics, should be used to lessen the likelihood of AKI. Adequate monitoring includes therapeutic drug monitoring, ongoing fluid status evaluations, and a continual reassessment of AKI risk. The issues with serum creatinine make the timely evaluation of renal function and diagnosis of the cause of AKI problematic. Most notably, concomitant piperacillin-tazobactam can increase serum creatinine via tubular secretion, resulting in higher rates of AKI being reported. The few studies evaluating the long-term prognosis of AKI in patients receiving vancomycin have found that few patients require renal replacement therapy and that the long-term risk of death is unaffected for patients surviving after the initial 28-day period." @default.
- W2948697889 created "2019-06-14" @default.
- W2948697889 creator A5016829551 @default.
- W2948697889 creator A5041675402 @default.
- W2948697889 date "2019-06-01" @default.
- W2948697889 modified "2023-09-26" @default.
- W2948697889 title "Utilizing the Patient Care Process to Minimize the Risk of Vancomycin-Associated Nephrotoxicity" @default.
- W2948697889 cites W1853085100 @default.
- W2948697889 cites W1905008412 @default.
- W2948697889 cites W1956069018 @default.
- W2948697889 cites W1967300023 @default.
- W2948697889 cites W1974917104 @default.
- W2948697889 cites W1978694850 @default.
- W2948697889 cites W1995503370 @default.
- W2948697889 cites W2001914137 @default.
- W2948697889 cites W2010066166 @default.
- W2948697889 cites W2011312924 @default.
- W2948697889 cites W2017404902 @default.
- W2948697889 cites W2020306249 @default.
- W2948697889 cites W2021041146 @default.
- W2948697889 cites W2027939741 @default.
- W2948697889 cites W2040162230 @default.
- W2948697889 cites W2048593869 @default.
- W2948697889 cites W2051628163 @default.
- W2948697889 cites W2057159770 @default.
- W2948697889 cites W2076664566 @default.
- W2948697889 cites W2078727847 @default.
- W2948697889 cites W2079928834 @default.
- W2948697889 cites W2096048295 @default.
- W2948697889 cites W2098479591 @default.
- W2948697889 cites W2102544848 @default.
- W2948697889 cites W2107538404 @default.
- W2948697889 cites W2111442039 @default.
- W2948697889 cites W2113522006 @default.
- W2948697889 cites W2116736766 @default.
- W2948697889 cites W2116814997 @default.
- W2948697889 cites W2123859227 @default.
- W2948697889 cites W2125700744 @default.
- W2948697889 cites W2126520713 @default.
- W2948697889 cites W2128927279 @default.
- W2948697889 cites W2133979383 @default.
- W2948697889 cites W2136152773 @default.
- W2948697889 cites W2136609531 @default.
- W2948697889 cites W2139937737 @default.
- W2948697889 cites W2141348928 @default.
- W2948697889 cites W2143206150 @default.
- W2948697889 cites W2143569590 @default.
- W2948697889 cites W2144504167 @default.
- W2948697889 cites W2149687213 @default.
- W2948697889 cites W2152771638 @default.
- W2948697889 cites W2158657903 @default.
- W2948697889 cites W2168908910 @default.
- W2948697889 cites W2172309875 @default.
- W2948697889 cites W2263915682 @default.
- W2948697889 cites W2296006889 @default.
- W2948697889 cites W2337544276 @default.
- W2948697889 cites W2473016454 @default.
- W2948697889 cites W2489206503 @default.
- W2948697889 cites W2523533059 @default.
- W2948697889 cites W2552795391 @default.
- W2948697889 cites W2559211671 @default.
- W2948697889 cites W2559772715 @default.
- W2948697889 cites W2576200217 @default.
- W2948697889 cites W2580351979 @default.
- W2948697889 cites W2591595902 @default.
- W2948697889 cites W2613483874 @default.
- W2948697889 cites W2621058175 @default.
- W2948697889 cites W2746653474 @default.
- W2948697889 cites W2765826512 @default.
- W2948697889 cites W2770585743 @default.
- W2948697889 cites W2774974184 @default.
- W2948697889 cites W2783138008 @default.
- W2948697889 cites W2794250316 @default.
- W2948697889 cites W2802934123 @default.
- W2948697889 cites W2885889074 @default.
- W2948697889 cites W2887297384 @default.
- W2948697889 cites W2888281395 @default.
- W2948697889 cites W2888995183 @default.
- W2948697889 cites W2898138633 @default.
- W2948697889 cites W2899983149 @default.
- W2948697889 cites W2911774236 @default.
- W2948697889 cites W2914477527 @default.
- W2948697889 cites W2919820653 @default.
- W2948697889 cites W2940061256 @default.
- W2948697889 cites W2949705127 @default.
- W2948697889 cites W2952762910 @default.
- W2948697889 cites W3024247247 @default.
- W2948697889 cites W3133528108 @default.
- W2948697889 cites W3217395775 @default.
- W2948697889 cites W4211018016 @default.
- W2948697889 doi "https://doi.org/10.3390/jcm8060781" @default.
- W2948697889 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6616424" @default.
- W2948697889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31159415" @default.
- W2948697889 hasPublicationYear "2019" @default.
- W2948697889 type Work @default.
- W2948697889 sameAs 2948697889 @default.
- W2948697889 citedByCount "6" @default.
- W2948697889 countsByYear W29486978892020 @default.